These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17652880)

  • 21. Prevention of limb amputation in patients with limbs ulcers by autologous peripheral blood mononuclear cell implantation.
    Kawamura A; Horie T; Tsuda I; Ikeda A; Egawa H; Imamura E; Iida J; Sakata H; Tamaki T; Kukita K; Meguro J; Yonekawa M; Kasai M
    Ther Apher Dial; 2005 Feb; 9(1):59-63. PubMed ID: 15828908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A clinical study on implantation of autologous bone marrow mononuclear cells after bone marrow stimulation for treatment of lower limb ischemia].
    Gu Y; Zhang J; Qi L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1017-20. PubMed ID: 17140078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells.
    Motukuru V; Suresh KR; Vivekanand V; Raj S; Girija KR
    J Vasc Surg; 2008 Dec; 48(6 Suppl):53S-60S; discussion 60S. PubMed ID: 19084740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analysis of clinical state for arteriosclerosis obliterans in lower extremity of diabetic patients on peritoneal dialysis].
    Shi JB; Sun QH; Nie JD; Sun LH; Zhang N; Han QF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Feb; 45(1):109-13. PubMed ID: 23411531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognostic factors for critical limb ischemia after autologous bone marrow implantation].
    Oda M; Kato K; Toba K; Otaki K; Kitajima T; Ikarashi N; Yanagawa T; Higashimura M; Asami F; Isoda M; Ozawa T; Moriyama M; Hirono S; Okura Y; Hanawa H; Kodama M; Aizawa Y
    J Cardiol; 2007 Oct; 50(4):235-42. PubMed ID: 17987839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoperipheral blood mononuclear cell transplantation improved giant ulcers due to chronic arteriosclerosis obliterans.
    Sugihara S; Yamamoto Y; Matsubara K; Ishida K; Matsuura T; Ando F; Igawa G; Narazaki G; Miake J; Tajima F; Nishio R; Nakayama B; Igawa O; Shigemasa C; Hisatome I
    Heart Vessels; 2006 Jul; 21(4):258-62. PubMed ID: 16865304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic angiogenesis by autologous bone marrow cell implantation for refractory chronic peripheral arterial disease using assessment of neovascularization by 99mTc-tetrofosmin (TF) perfusion scintigraphy.
    Miyamoto M; Yasutake M; Takano H; Takagi H; Takagi G; Mizuno H; Kumita S; Takano T
    Cell Transplant; 2004; 13(4):429-37. PubMed ID: 15468685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of neovascularization with mobilized blood cells transplantaion: supply of angioblasts and angiogenic cytokines.
    Zhou B; Liu PX; Lan HF; Fang ZH; Han ZB; Ren H; Poon MC; Han ZC
    J Cell Biochem; 2007 Sep; 102(1):183-95. PubMed ID: 17390342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autologous peripheral blood stem cell transplantation to treat thromboangiitis obliterans: preliminary results.
    Wan J; Yang Y; Ma ZH; Sun Y; Liu YQ; Li GJ; Zhang GM
    Eur Rev Med Pharmacol Sci; 2016; 20(3):509-13. PubMed ID: 26914127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A FOLLOW-UP STUDY ON AUTOLOGOUS BONE MARROW MONONUCLEAR CELLS TRANSPLANTATION FOR CRITICAL LOWER ARTERIOSCLEROSIS OBLITERANS IN DIABETIC PATIENTS].
    Dou Y; Zhao J; Zhang L; Wang X; Yuan H; Yuan C
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2015 Jul; 29(7):893-8. PubMed ID: 26540987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic outcomes of transplanting autologous granulocyte colony-stimulating factor-mobilised peripheral mononuclear cells in diabetic patients with critical limb ischaemia.
    Mohammadzadeh L; Samedanifard SH; Keshavarzi A; Alimoghaddam K; Larijani B; Ghavamzadeh A; Ahmadi AS; Shojaeifard A; Ostadali MR; Sharifi AM; Amini MR; Mahmoudian A; Fakhraei H; Aalaa M; Mohajeri-Tehrani MR
    Exp Clin Endocrinol Diabetes; 2013 Jan; 121(1):48-53. PubMed ID: 23329572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapeutic angiogenesis by autologous transplantation of bone-marrow cells in a patient with progressive limb ischemia due to arteriosclerosis obliterans: a case report].
    Hasebe H; Osada M; Kodama Y; Fujioka D; Sano K; Nakamura T; Mitsumori T; Nakamura K; Kitta Y; Ichiki Y; Obata J; Kawabata K; Yanagi M; Sano S; Takano H; Umetani K; Kugiyama K
    J Cardiol; 2004 Apr; 43(4):179-83. PubMed ID: 15125382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limb rescue: a new autologous-peripheral blood mononuclear cells technology in critical limb ischemia and chronic ulcers.
    De Angelis B; Gentile P; Orlandi F; Bocchini I; Di Pasquali C; Agovino A; Gizzi C; Patrizi F; Scioli MG; Orlandi A; Cervelli V
    Tissue Eng Part C Methods; 2015 May; 21(5):423-35. PubMed ID: 25341088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans.
    Durdu S; Akar AR; Arat M; Sancak T; Eren NT; Ozyurda U
    J Vasc Surg; 2006 Oct; 44(4):732-9. PubMed ID: 16926085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of autologous bone-marrow cell transplantation on ischemic ulcer in patients with Buerger's disease.
    Saito Y; Sasaki K; Katsuda Y; Murohara T; Takeshita Y; Okazaki T; Arima K; Katsuki Y; Shintani S; Shimada T; Akashi H; Ikeda H; Imaizumi T
    Circ J; 2007 Aug; 71(8):1187-92. PubMed ID: 17652879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Arteriosclerosis obliterans (ASO)].
    Koshikawa M; Ikeda U
    Nihon Rinsho; 2010 May; 68(5):926-9. PubMed ID: 20446594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Autologous peripheral blood stem cell transplantation for the treatment of lower extremity arterial occlusive disease].
    Wang L; Dong SM; Jiang QZ; Nan JL; Liu YG; Li SR; Feng XM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):345-8. PubMed ID: 16776930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of granulocyte-colony-stimulating factor administration following autologous intramuscular implantation of bone marrow mononuclear cells: a randomized controlled trial in patients with advanced lower limb ischemia.
    Zafarghandi MR; Ravari H; Aghdami N; Namiri M; Moazzami K; Taghiabadi E; Fazel A; Pournasr B; Farrokhi A; Sharifian RA; Salimi J; Moini M; Baharvand H
    Cytotherapy; 2010 Oct; 12(6):783-91. PubMed ID: 20078390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of autologous bone marrow mononuclear cells in six patients with advanced chronic critical limb ischemia as a result of diabetes: our experience.
    Subrammaniyan R; Amalorpavanathan J; Shankar R; Rajkumar M; Baskar S; Manjunath SR; Senthilkumar R; Murugan P; Srinivasan VR; Abraham S
    Cytotherapy; 2011 Sep; 13(8):993-9. PubMed ID: 21671823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial.
    Lu D; Chen B; Liang Z; Deng W; Jiang Y; Li S; Xu J; Wu Q; Zhang Z; Xie B; Chen S
    Diabetes Res Clin Pract; 2011 Apr; 92(1):26-36. PubMed ID: 21216483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.